2m 2m 2m 2m 2m 2m 2m
PROKIDNEY-A (PROK)
NASDAQ
$1.60-$0.02 (-0.93%)
Price as of Aug 21, 2026 7:41 PM EDT- $336.4MMarket Cap
- -33.20%1-Year Change
- BiotechnologyIndustry
PROKIDNEY-A (PROK)
$1.60-$0.02 (-0.93%)
PROK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.61 | ||
Change | +$0.19 (+13.38%) | ||
Open | $1.43 | ||
High | $1.62 | ||
Low | $1.43 | ||
Previous Close | $1.42 | ||
Volume | 1,725,776 | ||
30-Day Average Volume | 1,119,487 | ||
1-Week Change | 21.05% | ||
1-Month Change | 0.94% | ||
1-Year Change | -33.20% | ||
3-Year Change | -82.73% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 208.9M | ||
Total Assets | $249.0M | ||
Market Cap | $336.4M | ||
Enterprise Value | $261.5M | ||
Period: QTR TTM FY | |||
Revenue | $150,000.00 | ||
Net Income | -$28.4M | ||
Free Cash Flow | -$44.2M | ||
EBIT | -$28.4M | ||
EBITDA | -$26.7M | ||
Net Working Capital | $167.1M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 1,743 | ||
P/B | -0 | ||
P/E | -11 | ||
PEG | 2 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue